Tarka
- Product NDC
- 0074-3290
- Requested package NDC
- 0074-3290-13
- 11-digit product format
- 000743290
- Labeler code
- 0074
- Product ID
- 0074-3290_f9fce1b1-4300-ab41-7107-8328a4b01c60
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trandolapril and Verapamil Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AbbVie Inc.
- Application
- NDA020591
- Marketing category
- NDA
- Marketing start
- 1996-10-22
- Marketing end
- 2021-08-18
- Substance
- TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
- Active strength
- 4 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0074-3290 | 0074-3290-13 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020591-001 | TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | |
| N020591-002 | TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | |
| N020591-003 | TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | |
| N020591-004 | TARKA | TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020591-001 | TARKA | 2MG;180MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020591-002 | TARKA | 4MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020591-003 | TARKA | 1MG;240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020591-004 | TARKA | 2MG;240MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 1996-10-22 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020591-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020591-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N020591-004 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020591-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020591-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020591-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N020591-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020591-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N020591-004 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N020591-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020591-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N020591-004 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N020591-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020591-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N020591-004 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N020591-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020591-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N020591-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N020591-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020591-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N020591-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020591-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020591-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020591-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N020591-004 | AB | 1 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ea1f6fc8-bfc2-4421-a2eb-4e87c7c3e3c4 | Product name | 2 | 20230103 |
| 33ad674d-d105-6aa5-02fa-95ae4329b8cd | Product name | 2 | 20180809 |
| 3279bd6d-5b02-e60b-3857-c853a2deb2dd | Product name | 2 | 20170713 |
| 8ebb66e3-d7b3-f1e5-88aa-3369e64bb84a | Product name | 1 | 20140508 |
| 940a1faa-2df8-cc65-be37-1b97984b4ea3 | Product name | 1 | 20140508 |
| 980ce3cc-8943-91ef-56b2-a0bae7a2b9f9 | Product name | 1 | 20140508 |
| d3b67bc2-0e96-e3ec-06a9-90afcc07bf13 | Product name | 1 | 20140508 |
| e2fcd66c-a043-3187-790d-b0342deb1149 | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0074-3290-13 | EA - Each | 0074-3290 | 2f9466a6-52cd-48c4-9a13-f0b3f29f68a8 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 897785 | Tarka 2 MG / 180 MG 24HR Extended Release Oral Tablet | PSN | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897846 | Tarka 2 MG / 240 MG 24HR Extended Release Oral Tablet | PSN | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897855 | Tarka 4 MG / 240 MG 24HR Extended Release Oral Tablet | PSN | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897783 | trandolapril 2 MG / verapamil HCl 180 MG 24HR Extended Release Oral Tablet | PSN | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897844 | trandolapril 2 MG / verapamil HCl 240 MG 24HR Extended Release Oral Tablet | PSN | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897853 | trandolapril 4 MG / verapamil HCl 240 MG 24HR Extended Release Oral Tablet | PSN | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897785 | 24 HR trandolapril 2 MG / verapamil hydrochloride 180 MG Extended Release Oral Tablet [Tarka] | SBD | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897846 | 24 HR trandolapril 2 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet [Tarka] | SBD | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897855 | 24 HR trandolapril 4 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet [Tarka] | SBD | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897783 | 24 HR trandolapril 2 MG / verapamil hydrochloride 180 MG Extended Release Oral Tablet | SCD | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897844 | 24 HR trandolapril 2 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet | SCD | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897853 | 24 HR trandolapril 4 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet | SCD | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897785 | Tarka 2/180 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897785 | Tarka 2/180 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897846 | Tarka 2/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897846 | Tarka 2/240 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897855 | Tarka 4/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897855 | Tarka 4/240 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897783 | trandolapril 2 MG / verapamil hydrochloride 180 MG 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897844 | trandolapril 2 MG / verapamil hydrochloride 240 MG 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
| 897853 | trandolapril 4 MG / verapamil hydrochloride 240 MG 24 HR Extended Release Oral Tablet | SY | 3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0074-3290-13 | 00074329013 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3290-13) | 1996-10-22 | 2021-08-18 | No | No | Current |